Persistent URL of this record https://hdl.handle.net/1887/121521
In Collections
This item can be found in the following collections:
![Duohexabody-CD37, a Novel Bispecific Antibody with a Hexamerization-Enhancing Mutation Targeting CD37, Demonstrates Superior Complement-Dependent Cytotoxicity in Preclinical B-Cell Malignancy Models](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Duohexabody-CD37, a Novel Bispecific Antibody with a Hexamerization-Enhancing Mutation Targeting CD37, Demonstrates Superior Complement-Dependent Cytotoxicity in Preclinical B-Cell Malignancy Models
- All authors
- Oostindie, S.C.; Horst, H.J. van der; Overdijk, M.B.; Strumane, K.; Verploegen, S.; Lindorfer, M.A.; Cook, E.M.; Chamuleau, M.E.D.; Mutis, T.; Schuurman, J.; Sasser, A.K.; Taylor, R.P.; Parren, P.W.H.I.; Beurskens, F.J.; Breij, E.C.W.
- Date
- 2018-11-29
- Title of host publication
- Blood
- Volume
- 132